Noile-Immune

NeuleuMune Biotech is a company invested in by the National Cancer Center and Yamaguchi University, specializing in the development of cancer immunotherapy centered on CAR-T cell therapy. Their goal is to become a leading company guiding the next generation of cancer immunotherapy.